Douglas J R, Noga B R, Dai X, Jordan L M
Department of Physiology, University of Manitoba, Winnipeg, Canada.
J Neurosci. 1993 Mar;13(3):990-1000. doi: 10.1523/JNEUROSCI.13-03-00990.1993.
Development of pharmacological strategies for the control of locomotion in patients with spinal cord injury or disease requires an understanding of the neuroactive substances involved in the activation of the spinal cord neural systems for the control of locomotion. Studies using the in vitro preparations of the lamprey, frog embryo, and newborn rat indicate that excitatory amino acids (EAAs) are involved in the initiation of locomotion. The present study determines whether spinal EAA receptors play a role in locomotion in an in vivo, adult mammalian preparation. Experiments were performed on precollicular, postmammillary decerebrate cats, some of which were spinalized at the 13th thoracic segment. Cannulas for drug infusions were positioned intrathecally in the lumbar region of the spinal cord. A ligature around the spinal cord at the level of the 13th thoracic segment prevented rostral diffusion of the drugs. Locomotion was monitored with electromyograms in treadmill locomotion experiments and electroneurograms in fictive locomotion experiments. Intrathecal infusion of either the NMDA receptor antagonist 2-amino-5-phosphonovaleric acid or the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione blocked hindlimb treadmill and fictive locomotion induced by electrical stimulation of the mesencephalic locomotor region (MLR) of the midbrain. Intrathecal administration of NMDA elicited hindlimb fictive locomotion in resting animals similar to that evoked by electrical stimulation of the MLR. At lower concentrations, NMDA evoked either independent bursting activity in the various nerves or loosely organized rhythmicity showing little reciprocity between antagonists. In contrast, administration of the EAA uptake blocker dihydrokainic acid (DHK) evoked intermittent periods of bursting activity characterized by a variable duration and a high degree of reciprocity between flexors and extensors. Given together at low concentrations, NMDA and DHK produced a well-coordinated locomotor pattern. Kainate and quisqualate were ineffective in producing fictive locomotion. These results are consistent with the suggestion that EAAs play a role in the initiation of mammalian locomotion. Furthermore, the results are consistent with those obtained from the neonatal rat in vitro preparations.
开发用于控制脊髓损伤或疾病患者运动的药理学策略,需要了解参与激活脊髓神经系统以控制运动的神经活性物质。使用七鳃鳗、青蛙胚胎和新生大鼠的体外制剂进行的研究表明,兴奋性氨基酸(EAA)参与运动的启动。本研究确定脊髓EAA受体在成年哺乳动物体内制剂的运动中是否起作用。实验在脑桥前、乳头体后去大脑的猫身上进行,其中一些在第13胸段进行了脊髓横断。用于药物输注的套管置于脊髓腰段的鞘内。在第13胸段水平围绕脊髓的结扎可防止药物向头端扩散。在跑步机运动实验中用肌电图监测运动,在虚拟运动实验中用电神经图监测运动。鞘内注射NMDA受体拮抗剂2-氨基-5-磷酸缬氨酸或非NMDA受体拮抗剂6-氰基-7-硝基喹喔啉-2,3-二酮可阻断由电刺激中脑的中脑运动区(MLR)诱导的后肢跑步机运动和虚拟运动。鞘内注射NMDA可在静息动物中引发后肢虚拟运动,类似于由MLR电刺激诱发的运动。在较低浓度下,NMDA在各种神经中诱发独立的爆发活动或组织松散的节律性,拮抗剂之间几乎没有相互作用。相反,给予EAA摄取阻滞剂二氢海因酸(DHK)可诱发间歇性爆发活动,其特征为持续时间可变,屈肌和伸肌之间具有高度的相互作用。在低浓度下联合给予时,NMDA和DHK产生协调良好的运动模式。 kainate和quisqualate在产生虚拟运动方面无效。这些结果与EAA在哺乳动物运动启动中起作用的观点一致。此外,这些结果与从新生大鼠体外制剂获得的结果一致。